Liverpool Skylilne

Pharmacy and Biomolecular Sciences

Dr Giles Watts

Dr Giles Watts

Telephone: 0151 231 2416

Publications

Journal article

Raja M, Shelton JC, Salamat-Zadeh F, Tavakoli M, Donell S, Watts G, Vadgama P. 2019. An electrochemical study of acrylate bone adhesive permeability and selectivity change during in vitro ageing: A model approach to the study of biomaterials and membrane barriers Analytica Chimica Acta: X, 2 DOI

Morrison J, Watts G, Hobbs G, Dawnay N. 2018. Field-based detection of biological samples for forensic analysis: Established techniques, novel tools, and future innovations Forensic Science International, 285 :147-160 DOI Author Url Public Url

Mehta SG, Khare M, Ramani R, Watts GDJ, Simon M, Osann KE, Donkervoort S, Dec E, Nalbandian A, Platt J, Pasquali M, Wang A, Mozaffar T, Smith CD, Kimonis VE. 2013. Genotype-phenotype studies of VCP-associated inclusion body myopathy with Paget disease of bone and/or frontotemporal dementia Clinical Genetics, 83 :422-431 DOI Author Url

Nalbandian A, Llewellyn KJ, Badadani M, Yin HZ, Nguyen C, Katheria V, Watts G, Mukherjee J, Vesa J, Caiozzo V, Mozaffar T, Weiss JH, Kimonis VE. 2013. A progressive translational mouse model of human valosin-containing protein disease: The VCPR155H/+ mouse Muscle and Nerve, 47 :260-270 DOI Author Url

Nalbandian A, Llewellyn KJ, Kitazawa M, Yin HZ, Badadani M, Khanlou N, Edwards R, Nguyen C, Mukherjee J, Mozaffar T, Watts G, Weiss J, Kimonis VE. 2012. The Homozygote VCPR155H/R155H Mouse Model Exhibits Accelerated Human VCP-Associated Disease Pathology PLoS ONE, 7 DOI Author Url

Kimonis VE, Dec E, Badadani M, Nalbandian A, Vesa J, Caiozzo V, Wallace D, Martin B, Smith C, Watts GD. 2011. Clinical Spectrum of VCP Myopathy, Paget Disease, and Frontotemporal Dementia: Experimental Models and Potential Treatments :219-229 DOI

Nalbandian A, Donkervoort S, Dec E, Badadani M, Katheria V, Rana P, Nguyen C, Mukherjee J, Caiozzo V, Martin B, Watts GD, Vesa J, Smith C, Kimonis VE. 2011. The multiple faces of valosin-containing protein-associated diseases: Inclusion body myopathy with Paget's disease of bone, frontotemporal dementia, and amyotrophic lateral sclerosis Journal of Molecular Neuroscience, 45 :522-531 DOI Author Url

Badadani M, Nalbandian A, Watts GD, Vesa J, Kitazawa M, Su H, Tanaja J, Dec E, Wallace DC, Mukherjee J, Caiozzo V, Warman M, Kimonis VE. 2010. VCP associated inclusion body myopathy and paget disease of bone knock-in mouse model exhibits tissue pathology typical of human disease PLoS ONE, 5 DOI Author Url

Vesa J, Su H, Watts GD, Krause S, Walter MC, Martin B, Smith C, Wallace DC, Kimonis VE. 2009. Valosin containing protein associated inclusion body myopathy: abnormal vacuolization, autophagy and cell fusion in myoblasts Neuromuscular Disorders, 19 :766-772 DOI Author Url

Barohn RJ, Watts GDJ, Amato AA. 2009. A case of late-onset proximal and distal muscle weakness Neurology, 73 :1592-1597 DOI Author Url

Kimonis VE, Fulchiero E, Vesa J, Watts G. 2008. VCP disease associated with myopathy, Paget disease of bone and frontotemporal dementia: Review of a unique disorder Biochimica et Biophysica Acta - Molecular Basis of Disease, 1782 :744-748 DOI Author Url

Weihl CC, Temiz P, Miller SE, Watts G, Smith C, Forman M, Hanson PI, Kimonis V, Pestronk A. 2008. TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia Journal of Neurology, Neurosurgery & Psychiatry, 79 :1186-1189 DOI

Kimonis VE, Mehta SG, Fulchiero EC, Thomasova D, Pasquali M, Boycott K, Neilan EG, Kartashov A, Forman MS, Tucker S, Kimonis K, Mumm S, Whyte MP, Smith CD, Watts GDJ. 2008. Clinical studies in familial VCP myopathy associated with Paget disease of bone and frontotemporal dementia American Journal of Medical Genetics Part A, 146A :745-757 DOI

Watts GDG, Thomasova D, Ramdeen SK, Fulchiero EC, Mehta SG, Drachman DA, Weihl CC, Jamrozik Z, Kwiecinski H, Kaminska A, Kimonis VE. 2007. Novel VCP mutations in inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia Clinical Genetics, 72 :420-426 DOI Author Url

Hübbers CU, Clemen CS, Kesper K, Böddrich A, Hofmann A, Kämäräinen O, Tolksdorf K, Stumpf M, Reichelt J, Roth U, Krause S, Watts G, Kimonis V, Wattjes MP, Reimann J, Thal DR, Biermann K, Evert BO, Lochmüller H, Wanker EE, Schoser BGH, Noegel AA, Schröder R. 2007. Pathological consequences of VCP mutations on human striated muscle Brain, 130 :381-393 DOI Author Url

Forman MS, Mackenzie IR, Cairns NJ, Swanson E, Boyer PJ, Drachman DA, Jhaveri BS, Karlawish JH, Pestronk A, Smith TW, Tu PH, Watts GDJ, Markesbery WR, Smith CD, Kimonis VE. 2006. Novel ubiquitin neuropathology in frontotemporal dementia with valosin-containing protein gene mutations Journal of Neuropathology and Experimental Neurology, 65 :571-581 DOI Author Url

Mehta SG, Watts GDJ, McGillivray B, Mumm S, Hamilton SJ, Ramdeen S, Novack D, Briggs C, Whyte MP, Kimonis VE. 2006. Manifestations in a family with autosomal dominant bone fragility and limb-girdle myopathy American Journal of Medical Genetics Part A, 140A :322-330 DOI

Lucas GJA, Mehta SG, Hocking LJ, Stewart TL, Cundy T, Nicholson GC, Walsh JP, Fraser WD, Watts GDJ, Ralston SH, Kimonis VE. 2006. Evaluation of the role of Valosin-containing protein in the pathogenesis of familial and sporadic Paget's disease of bone Bone, 38 :280-285 DOI Author Url

Kuhlenbäumer G, Hannibal MC, Nelis E, Schirmacher A, Verpoorten N, Meuleman J, Watts GDJ, De Vriendt E, Young P, Stögbauer F, Halfter H, Irobi J, Goossens D, Del-Favero J, Betz BG, Hor H, Kurlemann G, Bird TD, Airaksinen E, Mononen T, Serradell AP, Prats JM, Van Broeckhoven C, De Jonghe P, Timmerman V, Ringelstein EB, Chance PF. 2005. Mutations in SEPT9 cause hereditary neuralgic amyotrophy Nature Genetics, 37 :1044-1046 DOI Author Url

Kimonis VE, Watts GDJ. 2005. Autosomal dominant inclusion body myopathy, Paget disease of bone, and frontotemporal dementia Alzheimer Disease and Associated Disorders, 19 DOI Author Url

Schröder R, Watts GDJ, Mehta SG, Evert BO, Broich P, Fließbach K, Pauls K, Hans VH, Kimonis V, Thal DR. 2005. Mutant valosin-containing protein causes a novel type of frontotemporal dementia Annals of Neurology, 57 :457-461 DOI Author Url

Watts GDJ, Wymer J, Kovach MJ, Mehta SG, Mumm S, Darvish D, Pestronk A, Whyte MP, Kimonis VE. 2004. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein Nature Genetics, 36 :377-381 DOI Author Url

Hünermund G, Schirmacher A, Ringelstein B, Young P, Watts GD, Meuleman J, Nelis E, Chance PF, Timmerman V, Stögbauer F, Kuhlenbäumer G. 2004. Genomic organization and mutation analysis of three candidate genes for hereditary neuralgic amyotrophy Muscle and Nerve, 29 :601-604 DOI Author Url

Watts GDJ, Thorne M, Kovach MJ, Pestronk A, Kimonis VE. 2003. Clinical and genetic heterogeneity in chromosome 9p associated hereditary inclusion body myopathy: Exclusion of GNE and three other candidate genes Neuromuscular Disorders, 13 :559-567 DOI Author Url

Watts GDJ, O'Briant KC, Chance PF. 2002. Evidence of a founder effect and refinement of the hereditary neuralgic amyotrophy (HNA) locus on 17q25 in American families Human Genetics, 110 :166-172 DOI Author Url

Watts GDJ, Chance PF. 2002. Molecular basis of hereditary neuropathies. Advances in neurology, 88 :133-146 Author Url

Jeannet PY, Watts GDJ, Bird TD, Chance PF. 2001. Craniofacial and cutaneous findings expand the phenotype of hereditary neuralgic amyotrophy Neurology, 57 :1963-1968 DOI Author Url

Watts GDJ, O'Briant KC, Borreson TE, Windebank AJ, Chance PF. 2001. Evidence for genetic heterogeneity in hereditary neuralgic amyotrophy Neurology, 56 :675-678 DOI Author Url

Byrd P. 1996. A gene transcribed from the bidirectional ATM promoter coding for a serine rich protein: amino acid sequence, structure and expression studies Human Molecular Genetics, 5 :1785-1791 DOI

Camacho-Vanegas O, Camacho SC, Till J, Miranda-Lorenzo I, Terzo E, Ramirez MC, Schramm V, Cordovano G, Watts G, Mehta S, Kimonis V, Hoch B, Philibert KD, Raabe CA, Bishop DF, Glucksman MJ, Martignetti JA. Primate Genome Gain and Loss: A Bone Dysplasia, Muscular Dystrophy, and Bone Cancer Syndrome Resulting from Mutated Retroviral-Derived MTAP Transcripts The American Journal of Human Genetics, 90 :614-627 DOI

Greenberg SA, Watts GD, Kimonis VE, Amato AA, Pinkus JL. Nuclear localization of valosin-containing protein in normal muscle and muscle affected by inclusion-body myositis Muscle & Nerve, 36 :447-454 DOI

Mehta SG, Watts GD, Adamson JL, Hutton M, Umberger G, Xiong S, Ramdeen S, Lovell MA, Kimonis VE, Smith CD. APOE is a potential modifier gene in an autosomal dominant form of frontotemporal dementia (IBMPFD) Genetics in Medicine, 9 :9-13 DOI

Watts GDJ, Mehta SG, Zhao C, Ramdeen S, Hamilton SJ, Novack DV, Mumm S, Whyte MP, Mc Gillivray B, Kimonis VE. Mapping autosomal dominant progressive limb-girdle myopathy with bone fragility to chromosome 9p21-p22: a novel locus for a musculoskeletal syndrome Human Genetics, 118 :508-514 DOI

Kesper K, Watts G, Mehta S, Wattjes M, Reimann J, Fließbach K, Thal D, Lutterbey G, Evert B, Klockgether T, Kimonis V, Schröder R. Valosin-containing protein aggregation in inclusion body myopathy associated with Paget disease of the bone and frontotemporal dementia Aktuelle Neurologie, 31 DOI

Stankovic T, Byrd PJ, Cooper PR, McConville CM, Munroe DJ, Riley JH, Watts GDJ, Ambrose H, McGuire G, Smith AD, Sutcliffe A, Mills T, Taylor AMR. Construction of a Transcription Map around the Gene for Ataxia Telangiectasia: Identification of at Least Four Novel Genes Genomics, 40 :267-276 DOI

Dawnay N, McColl S, Morrison J, Louhelainen J, Sheppard K, May A, Girdland-Flink L, Watts G. Assessing the performance of quantity and quality metrics using the QIAGEN Investigator® Quantiplex® Pro RGQ kit Science and Justice, DOI Author Url Public Url

Editorial/letter to the editor

Watts GDJ, Donell S. 2016. Breech presentation is a risk factor for dysplasia of the femoral trochlea Acta Orthopaedica, 87 :207-208 DOI